Butterfly Network Inc
BFLY1.440USD
+0.040+2.86%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
361.49MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Butterfly Network Inc Unternehmen
Butterfly Network, Inc. is a digital health company. The Company is focused on transforming care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. It has two portable ultrasound devices on the market: second-generation Butterfly iQ+ and third-generation Butterfly iQ3. Butterfly iQ+/iQ3 are both powered by its Ultrasound-on-Chip technology, allowing them to power whole-body imaging on a single handheld probe using digital semiconductor technology. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Within the Butterfly application, users can utilize up to six imaging modes, including B-Mode, Color Doppler, M-Mode, Power Doppler, Pulsed-Wave Doppler, and Biplane Imaging.
Unternehmensinformationen
BörsenkürzelBFLY
Name des UnternehmensButterfly Network Inc
IPO-datumMay 26, 2020
CEODr. Joseph M. (Joe) Devivo
Anzahl der mitarbeiter190
WertpapierartOrdinary Share
GeschäftsjahresendeMay 26
Addresse1600 District Avenue
StadtBURLINGTON
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl01803
Telefon17815574800
Websitehttps://www.butterflynetwork.com/
BörsenkürzelBFLY
IPO-datumMay 26, 2020
CEODr. Joseph M. (Joe) Devivo
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
9.65M
+0.84%
Dr. Joseph M. (Joe) Devivo
Dr. Joseph M. (Joe) Devivo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.43M
+67.94%
Mr. Steve Cashman
Mr. Steve Cashman
Chief Business Officer
Chief Business Officer
502.59K
-77.90%
Mr. Larry Robbins
Mr. Larry Robbins
Lead Independent Director
Lead Independent Director
365.50K
+187.40%
Ms. Dawn Carfora
Ms. Dawn Carfora
Independent Director
Independent Director
219.62K
+57.79%
Dr. Andrei G. Stoica, Ph.D.
Dr. Andrei G. Stoica, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Elazer Edelman, M.D., Ph.D.
Dr. Elazer Edelman, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Erica G. Schwartz, M.D., J.D.
Dr. Erica G. Schwartz, M.D., J.D.
Independent Director
Independent Director
--
--
Ms. S. Louise Phanstiel, CPA
Ms. S. Louise Phanstiel, CPA
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
9.65M
+0.84%
Dr. Joseph M. (Joe) Devivo
Dr. Joseph M. (Joe) Devivo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.43M
+67.94%
Mr. Steve Cashman
Mr. Steve Cashman
Chief Business Officer
Chief Business Officer
502.59K
-77.90%
Mr. Larry Robbins
Mr. Larry Robbins
Lead Independent Director
Lead Independent Director
365.50K
+187.40%
Ms. Dawn Carfora
Ms. Dawn Carfora
Independent Director
Independent Director
219.62K
+57.79%
Dr. Andrei G. Stoica, Ph.D.
Dr. Andrei G. Stoica, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Hardware
14.16M
66.73%
Software and other services
7.06M
33.27%
Nach RegionUSD
Name
Umsatz
Anteil
United States
17.04M
80.28%
International
4.19M
19.72%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Hardware
14.16M
66.73%
Software and other services
7.06M
33.27%
Aktionärsstatistik
Aktualisiert: Thu, May 22
Aktualisiert: Thu, May 22
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Fosun International Ltd
4.85%
Glenview Capital Management, LLC
4.51%
Rothberg (Jonathan M)
4.37%
The Vanguard Group, Inc.
3.88%
Capital Research Global Investors
3.84%
Other
78.55%
Aktionäre
Aktionäre
Anteil
Fosun International Ltd
4.85%
Glenview Capital Management, LLC
4.51%
Rothberg (Jonathan M)
4.37%
The Vanguard Group, Inc.
3.88%
Capital Research Global Investors
3.84%
Other
78.55%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
24.01%
Hedge Fund
10.38%
Investment Advisor/Hedge Fund
8.67%
Individual Investor
6.98%
Holding Company
4.85%
Corporation
2.06%
Research Firm
2.03%
Foundation
0.46%
Pension Fund
0.31%
Other
40.26%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
452
132.08M
59.80%
+19.64M
2025Q1
463
134.83M
61.70%
+30.88M
2024Q4
439
95.60M
44.26%
+1.75M
2024Q3
436
81.98M
42.82%
-15.90M
2024Q2
437
84.70M
45.43%
-25.58M
2024Q1
443
102.66M
55.89%
-10.36M
2023Q4
445
101.26M
55.91%
-15.86M
2023Q3
456
105.48M
58.39%
-19.66M
2023Q2
472
110.05M
61.35%
-5.29M
2023Q1
486
98.46M
55.67%
-23.16M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fosun International Ltd
10.72M
4.85%
--
--
Mar 31, 2025
Glenview Capital Management, LLC
9.96M
4.51%
--
--
Jun 13, 2025
Rothberg (Jonathan M)
9.65M
4.37%
+80.43K
+0.84%
Jun 13, 2025
The Vanguard Group, Inc.
8.57M
3.88%
+1.13M
+15.21%
Mar 31, 2025
Capital Research Global Investors
8.49M
3.84%
+7.13M
+524.60%
Mar 31, 2025
Capital World Investors
8.49M
3.84%
+7.13M
+524.60%
Mar 31, 2025
ARK Investment Management LLC
7.02M
3.18%
+1.01M
+16.84%
Mar 31, 2025
First Light Asset Management, LLC
5.51M
2.49%
+1.51M
+37.83%
Mar 31, 2025
Hood River Capital Management LLC
4.95M
2.24%
+4.95M
--
Mar 31, 2025
Longview Investors LLC
4.55M
2.06%
--
--
Jun 13, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
ARK Genomic Revolution ETF
1.23%
SPDR S&P Health Care Equipment ETF
0.81%
Global X HealthTech ETF
0.37%
SPDR S&P Kensho New Economies Composite ETF
0.16%
iShares Micro-Cap ETF
0.09%
iShares U.S. Medical Devices ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
Global X Russell 2000 ETF
0.02%
Mehr Anzeigen
ARK Genomic Revolution ETF
Anteil1.23%
SPDR S&P Health Care Equipment ETF
Anteil0.81%
Global X HealthTech ETF
Anteil0.37%
SPDR S&P Kensho New Economies Composite ETF
Anteil0.16%
iShares Micro-Cap ETF
Anteil0.09%
iShares U.S. Medical Devices ETF
Anteil0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.03%
iShares Russell 2000 Growth ETF
Anteil0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0.03%
Global X Russell 2000 ETF
Anteil0.02%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
